EUVIMEDEUVIMED entdecken
Crossref

Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats

Gleice K Silva-Cardoso, Willian Lazarini-Lopes, Eduardo Octaviano Primini, Jaime E Hallak, José A Crippa, Antônio W Zuardi, Norberto Garcia-Cairasco, Christie R A Leite-Panissi

Behavioural Brain Research · 2023

DOI: 10.1016/j.bbr.2023.114588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Behavioural Brain Research, 2023. Verfasst von Gleice K Silva-Cardoso und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, School of Philosophy, Science and Letters of Ribeirão Preto, University of São Paulo, Brazil; National Institute for Transl…. Hauptthemen laut MEDLINE: Cannabidiol, Neuralgia. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 112 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic neuropathic pain (CNP) is a vast world health problem often associated with the somatosensory domain. This conceptualization is problematic because, unlike most other sensations that are usually affectively neutral and may present emotional, affective, and cognitive impairments. Neuronal circuits that modulate pain can increase or decrease painful sensitivity based on several factors, including context and expectation. The objective of this study was to evaluate whether subchronic treatment with Cannabidiol (CBD; 0.3, 3, and 10 mg/kg intraperitoneal route - i.p., once a day for 3 days) could promote pain-conditioned reversal, in the conditioned place preference (CPP) test, in male Wistar rats submitted to chronic constriction injury (CCI) of the sciatic nerve. Then, we evaluated the expression of astrocytes and microglia in animals treated with CBD through the immunofluorescence technique. Our results demonstrated that CBD promoted the reversal of CPP at 3 and 10 mg/kg. In CCI animals, CBD was able to attenuate the increase in neuronal hyperactivity, measured by FosB protein expression, in the regions of the corticolimbic circuit: anterior cingulate cortex (ACC), complex basolateral amygdala (BLA), granular layer of the dentate gyrus (GrDG), and dorsal hippocampus (DH) - adjacent to subiculum (CA1). CBD also prevented the increased expression of GFAP and IBA-1 in CCI animals. We concluded that CBD effects on CNP are linked to the modulation of the aversive component of pain. These effects decrease chronic neuronal activation and inflammatory markers in regions of the corticolimbic circuit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolNeuralgiaRatsAnimalsMaleRats, WistarAvoidance LearningNeuroinflammatory Diseases

Stichwörter der Autor:innen

CannabidiolChronic painConditioned place preferenceFosB proteinGFAPIBA-1

Substanzen

Cannabidiol

Autor:innen und Institutionen

  • Department of Psychology, School of Philosophy, Science and Letters of Ribeirão Preto, University of São Paulo, Brazil; National Institute for Translational Medicine (INCT-TM; CNPq), São Paulo, Brazil.
  • Department of Neuroscience and Behavioral Sciences, Ribeirão Preto School of Medicine, University of São Paulo, Brazil; Department of Pharmacology, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Pr…
  • Department of Psychology, School of Philosophy, Science and Letters of Ribeirão Preto, University of São Paulo, Brazil.
  • Department of Neuroscience and Behavioral Sciences, Ribeirão Preto School of Medicine, University of São Paulo, Brazil; National Institute for Translational Medicine (INCT-TM; CNPq), São Paulo, Brazil.
  • Department of Neuroscience and Behavioral Sciences, Ribeirão Preto School of Medicine, University of São Paulo, Brazil; Department of Physiology, Ribeirão Preto School of Medicine, University of São Paulo, Brazil.
  • Department of Psychology, School of Philosophy, Science and Letters of Ribeirão Preto, University of São Paulo, Brazil; National Institute for Translational Medicine (INCT-TM; CNPq), São Paulo, Brazil. Electronic addres…

Zitieren

APA

Silva-Cardoso, G. K., Lazarini-Lopes, W., Primini, E. O., Hallak, J. E., Crippa, J. A., Zuardi, A. W., Garcia-Cairasco, N., & Leite-Panissi, C. R. A. (2023). Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2023.114588

Vancouver

Silva-Cardoso GK, Lazarini-Lopes W, Primini EO, Hallak JE, Crippa JA, Zuardi AW, et al. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats. Behavioural Brain Research. 2023. doi:10.1016/j.bbr.2023.114588

BibTeX
@article{SilvaCardoso2023,
  author = {Silva-Cardoso, Gleice K and Lazarini-Lopes, Willian and Primini, Eduardo Octaviano and Hallak, Jaime E and Crippa, José A and Zuardi, Antônio W and Garcia-Cairasco, Norberto and Leite-Panissi, Christie R A},
  title = {Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats},
  journal = {Behavioural Brain Research},
  year = {2023},
  doi = {10.1016/j.bbr.2023.114588}
}
Kostenlos starten →